SI-BONE Inc’s recently made public that its Director Freund John Gordon unloaded Company’s shares for reported $0.19 million on Aug 08 ’25. In the deal valued at $15.99 per share,12,132 shares were sold. As a result of this transaction, Freund John Gordon now holds 91,767 shares worth roughly $1.39 million.
Then, DUNN JEFFREY W sold 293 shares, generating $5,091 in total proceeds. Upon selling the shares at $17.37, the Director now owns 11,647 shares.
Before that, FRANCIS LAURA sold 757 shares. SI-BONE Inc shares valued at $13,823 were divested by the Chief Executive Officer at a price of $18.26 per share. As a result of the transaction, FRANCIS LAURA now holds 362,141 shares, worth roughly $5.5 million.
Needham reiterated its SI-BONE Inc [SIBN] rating to a Buy in a research note published on August 06, 2024; the price target was $19. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in late March with a ‘”an Overweight”‘ rating. Jefferies began covering SIBN with “Buy” recommendation on October 12, 2022.
Price Performance Review of SIBN
On Tuesday, SI-BONE Inc [NASDAQ:SIBN] saw its stock fall -1.30% to $15.2. Over the last five days, the stock has lost -5.00%. SI-BONE Inc shares have risen nearly 6.82% since the year began. Nevertheless, the stocks have risen 8.42% over the past one year. While a 52-week high of $20.05 was reached on 05/16/25, a 52-week low of $11.70 was recorded on 04/09/25.
Levels Of Support And Resistance For SIBN Stock
The 24-hour chart illustrates a support level at 15.01, which if violated will result in even more drops to 14.83. On the upside, there is a resistance level at 15.54. A further resistance level may holdings at 15.89.
How much short interest is there in SI-BONE Inc?
A steep rise in short interest was recorded in SI-BONE Inc stocks on 2025-07-31, dropping by 93317.0 shares to a total of 1.87 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 1.96 million shares. There was a decline of -4.99%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on June 08, 2021 when Citigroup began covering the stock and recommended ‘”a Buy”‘ rating along with a $40 price target.
